Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1–a statement of the ESCWorking Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke
- 26 January 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (5), 541-543
- https://doi.org/10.1093/eurheartj/ehaa1081
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokeEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2019